BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,134,700 | +82258.5% | 12,510,000 | +83300.0% | 0.00% | – |
| Q2 2023 | $14,734 | -4.3% | 15,000 | 0.0% | 0.00% | – |
| Q1 2023 | $15,390 | -3.3% | 15,000 | 0.0% | 0.00% | – |
| Q4 2022 | $15,920 | +6.1% | 15,000 | 0.0% | 0.00% | – |
| Q3 2022 | $15,000 | -99.7% | 15,000 | -99.7% | 0.00% | -100.0% |
| Q2 2022 | $5,455,000 | -34.0% | 5,510,000 | -33.4% | 0.00% | 0.0% |
| Q1 2022 | $8,267,000 | -45.2% | 8,271,000 | -42.7% | 0.00% | 0.0% |
| Q4 2021 | $15,082,000 | +39.4% | 14,424,000 | +36.4% | 0.00% | 0.0% |
| Q3 2021 | $10,822,000 | -32.3% | 10,577,000 | -31.5% | 0.00% | -50.0% |
| Q2 2021 | $15,996,000 | +161.1% | 15,435,000 | +154.9% | 0.00% | +100.0% |
| Q1 2021 | $6,127,000 | +118.1% | 6,055,000 | +131.3% | 0.00% | – |
| Q4 2020 | $2,809,000 | +107.8% | 2,618,000 | +103.3% | 0.00% | – |
| Q3 2020 | $1,352,000 | -73.6% | 1,288,000 | -69.3% | 0.00% | -100.0% |
| Q2 2020 | $5,130,000 | +82.7% | 4,198,000 | +56.7% | 0.00% | 0.0% |
| Q1 2020 | $2,808,000 | -72.3% | 2,679,000 | -72.1% | 0.00% | 0.0% |
| Q4 2019 | $10,150,000 | +121.3% | 9,608,000 | +106.0% | 0.00% | 0.0% |
| Q3 2019 | $4,586,000 | +23.3% | 4,665,000 | +30.2% | 0.00% | 0.0% |
| Q2 2019 | $3,719,000 | -16.7% | 3,583,000 | -17.9% | 0.00% | 0.0% |
| Q1 2019 | $4,466,000 | +39.2% | 4,365,000 | +35.3% | 0.00% | 0.0% |
| Q4 2018 | $3,209,000 | -13.6% | 3,227,000 | -13.4% | 0.00% | 0.0% |
| Q4 2017 | $3,713,000 | -3.2% | 3,727,000 | -1.5% | 0.00% | 0.0% |
| Q3 2017 | $3,835,000 | – | 3,785,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |